SCHEMBL14033749

SCHEMBL14033749

ClC(c1ccccc1)c1ccc(Br)cn1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
S1PR3 Q99500 10/20 0.51
S1PR4 O95977 5/20 0.51
S1PR2 O95136 3/20 0.45
ALDH1A1 P00352 5/20 0.38
TSHR P16473 1/20 0.37
HTR2A P28223 1/20 0.36
KDM4E B2RXH2 1/20 0.36
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033932 1.00 S1PR3 (0.51) S1PR3S1PR4S1PR2ALDH1A1TSHR
SCHEMBL14033593 0.84 S1PR3 (0.43) S1PR3S1PR4S1PR2TSHRRAB9A
SCHEMBL14033306 0.84 S1PR3 (0.43) S1PR3S1PR4S1PR2TSHRRAB9A
SCHEMBL29279115 0.81 SLC6A2 (0.53) S1PR3S1PR4S1PR2ALDH1A1HTR2A
SCHEMBL17479493 0.79 S1PR3 (0.49) S1PR3S1PR4S1PR2ALDH1A1HTR2A
SCHEMBL4602819 0.79 S1PR3 (0.43) S1PR3S1PR4S1PR2MEN1KMT2A
SCHEMBL14033902 0.78 TRPV1 (0.39) S1PR3S1PR4S1PR2
SCHEMBL14033813 0.78 TRPV1 (0.39) S1PR3S1PR4S1PR2
SCHEMBL5514077 0.78 S1PR3 (0.48) S1PR3S1PR4S1PR2ALDH1A1HTR2A
SCHEMBL14034090 0.75 NPC1 (0.36) S1PR3S1PR4ALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed